Immunogenicity and Neutralizing Activity Comparison of SARS-CoV-2 Spike Full-Length and Subunit Domain Proteins in Young Adult and Old-Aged Mice

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to be expanding the pandemic disease across the globe. Although SARS-CoV-2 vaccines were rapidly developed and approved for emergency use of vaccination in humans, supply and production difficulties are slowing down the global va...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ki-Hye, Bhatnagar, Noopur, Jeeva, Subbiah, Oh, Judy, Park, Bo Ryoung, Shin, Chong Hyun, Wang, Bao-Zhong, Kang, Sang-Moo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066235/
https://www.ncbi.nlm.nih.gov/pubmed/33805473
http://dx.doi.org/10.3390/vaccines9040316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066235/
https://www.ncbi.nlm.nih.gov/pubmed/33805473
http://dx.doi.org/10.3390/vaccines9040316

Ejemplares similares